Stocksigma LogoStocksigma Logo

Galaxy Medicare Limited Releases Investor Presentation Outlining Financials and Growth Strategy

Galaxy Medicare reported FY26 revenue of ₹400 Mn with an EBITDA margin of 10.75% and PAT of ₹34 Mn. Revenue channels were led by OEM/contract manufacturing

Galaxy Medicare Limited Releases Investor Presentation Outlining Financials and Growth Strategy

Galaxy Medicare Ltd · Investor Presentation · 24 Oct 2026, 11:23 pm

Galaxy Medicare Limited Releases Investor Presentation Outlining Financials and Growth Strategy Galaxy Medicare reported FY26 revenue of ₹400 Mn with an EBITDA margin of 10.75% and PAT of ₹34 Mn. Revenue channels were led by OEM/contract manufacturing at 47.8%, exports and trading at 24.5%, and domestic own brands at 22.5%. Core products—POP and Elastic Adhesive Bandages—accounted for 87% of FY26 revenue, operating at 106% and 91% capacity utilisation, respectively. Following its IPO filing on NSE EMERGE in FY25, the company is executing capacity expansions and backward integration to drive margin growth.

Original exchange filing (PDF)

More announcements from Galaxy Medicare Ltd

All Galaxy Medicare Ltd announcements